# The Effect of Therapy Combination in PCOS With Dlbs 3233

> **NCT07403201** · EARLY_PHASE1 · RECRUITING · sponsor: **Inlacinpenelitian** · enrollment: 90 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **COMBINATION_PRODUCT:** dlbs 3233 , clomifen citrat

## Key facts

- **NCT ID:** NCT07403201
- **Lead sponsor:** Inlacinpenelitian
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-15
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07403201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07403201, "The Effect of Therapy Combination in PCOS With Dlbs 3233". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07403201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*